Spruce biosciences to present at the oppenheimer 34th annual healthcare life sciences conference

South san francisco, calif.--(business wire)--spruce biosciences, inc. (nasdaq: sprb), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that javier szwarcberg, m.d., m.p.h., chief executive officer, will present at the oppenheimer 34th annual healthcare life sciences conference on february 13, 2024 at 2:40 p.m. et. interested parties can access the live webcast here.
SPRB Ratings Summary
SPRB Quant Ranking